Exploring the therapeutic potential of phytochemicals in Aloe barbadensis miller through molecular docking for ulcerative colitis management

Year : 2026 | Volume : 13 | 01 | Page :
    By

    Blessy Jacob,

  • Anusha K.B,

  • Vineeth Chandy,

  1. Associate Professor, Department of Pharmaceutical Chemistry, T John College of Pharmacy, Bengaluru, Karnataka, India
  2. Student, Department of Pharmaceutical Chemistry, T John College of Pharmacy, Bengaluru, Karnataka, India
  3. Principal, T John College of Pharmacy, Bengaluru, Karnataka, India

Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by mucosal inflammation of the colon, often associated with immune dysregulation and oxidative stress. Natural compounds have gained significant attention as alternative therapeutic agents due to their efficacy and minimal side effects. Quercetin, a flavonoid abundantly found in Allium cepa (onion), has demonstrated potent anti-inflammatory and antioxidant properties. This study employs an in silico approach to evaluate the therapeutic potential of quercetin as a modulator of key inflammatory pathways implicated in UC pathogenesis. Molecular docking studies were conducted to assess the binding affinity of quercetin against pivotal inflammatory targets such as TNF-α, IL-6, COX-2, and NF-κB. Additionally, ADME (Absorption, Distribution, Metabolism, and Excretion) profiling and drug-likeness evaluations were performed using SwissADME and pkCSM tools to determine its pharmacokinetic suitability. The docking results revealed favorable binding interactions of quercetin with all selected targets, suggesting its potential role in modulating inflammatory responses. Pharmacokinetic analyses indicated good oral bioavailability, high gastrointestinal absorption, and a low risk of toxicity. These findings suggest that quercetin from Allium cepa could be a promising natural therapeutic candidate for managing ulcerative colitis by targeting multiple inflammatory pathways. Further in vitro and in vivo investigations are warranted to validate these computational insights.

Keywords: Quercetin, Allium cepa, Ulcerative colitis, Molecular docking, Inflammatory pathways

How to cite this article:
Blessy Jacob, Anusha K.B, Vineeth Chandy. Exploring the therapeutic potential of phytochemicals in Aloe barbadensis miller through molecular docking for ulcerative colitis management. Research & Reviews: A Journal of Pharmacognosy. 2025; 13(01):-.
How to cite this URL:
Blessy Jacob, Anusha K.B, Vineeth Chandy. Exploring the therapeutic potential of phytochemicals in Aloe barbadensis miller through molecular docking for ulcerative colitis management. Research & Reviews: A Journal of Pharmacognosy. 2025; 13(01):-. Available from: https://journals.stmjournals.com/rrjopc/article=2025/view=229399


References

1. Bahrami G, Malekshahi H, Miraghaee S, Madani H, Babaei A, Mohammadi B, Hatami R. Protective and Therapeutic Effects of Aloe Vera Gel on Ulcerative Colitis Induced by Acetic Acid in Rats. Clin Nutr Res. 2020 Jul;9(3):223-234. https://doi.org/10.7762/cnr.2020.9.3.223
2. Naini MA, Zargari-Samadnejad A, Mehrvarz S, Tanideh R, Ghorbani M, Dehghanian A, Hasanzarrini M, Banaee F, Koohi-Hosseinabadi O, Tanideh N, Iraji A. Anti-Inflammatory, Antioxidant, and Healing-Promoting Effects of Aloe vera Extract in the Experimental Colitis in Rats. Evid Based Complement Alternat Med. 2021 Dec 6;2021:9945244. doi: 10.1155/2021/9945244. PMID: 34912469; PMCID: PMC8668319.
3. Maryam Akaberi, Zahra Sobhani, Behjat Javadi, Amirhossein Sahebkar, Seyed Ahmad Emami, Therapeutic effects of Aloe spp. in traditional and modern medicine: A review, Biomedicine & Pharmacotherapy, Volume 84, 2016, Pages 759-772.
4. Arora, Akshita1; Sharma, Nitin1; Kakkar, Dipti2. Natural polysaccharides for ulcerative colitis: A general overview. Asian Pacific Journal of Tropical Biomedicine 13(5):p 185-194, May 2023. | DOI: 10.4103/2221-1691.377405
5. Wan P, Chen H, Guo Y, Bai AP. Advances in treatment of ulcerative colitis with herbs: from bench to bedside. World J Gastroenterol. 2014 Oct 21;20(39):14099-104. doi: 10.3748/wjg.v20.i39.14099. PMID: 25339799; PMCID: PMC4202341.
6. Hamman JH. Composition and applications of Aloe vera leaf gel. Molecules. 2008 Aug 8;13(8):1599-616. doi: 10.3390/molecules13081599. PMID: 18794775; PMCID: PMC6245421.
7. Surjushe A, Vasani R, Saple DG. Aloe vera: a short review. Indian J Dermatol. 2008;53(4):163-6. doi: 10.4103/0019-5154.44785. PMID: 19882025; PMCID: PMC2763764.
8. Svitina H, Hamman JH, Gouws C. Molecular mechanisms and associated cell signalling pathways underlying the anticancer properties of phytochemical compounds from Aloe species (Review). Exp Ther Med. 2021 Aug;22(2):852. doi: 10.3892/etm.2021.10284. Epub 2021 Jun 8. PMID: 34178125; PMCID: PMC8220653.
9. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009 Dec;30(16):2785-91. doi: 10.1002/jcc.21256. PMID: 19399780; PMCID: PMC2760638.
10. Surjushe A, Vasani R, Saple DG. Aloe vera: a short review. Indian J Dermatol. 2008;53(4):163–166. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763764/
11. Reynolds T, Dweck AC. Aloe vera leaf gel: a review update. J Ethnopharmacol. 1999;68(1–3):3–37. doi:10.1016/S0378-8741(99)00085-9
12. Eshun K, He Q. Aloe vera: a valuable ingredient for the food, pharmaceutical and cosmetic industries—A review. Crit Rev Food Sci Nutr. 2004;44(2):91–96. doi:10.1080/10408690490424694
13. Choi S, Chung MH. A review on the relationship between Aloe vera components and their biologic effects. Semin Integr Med. 2003;1(1):53–62. doi:10.1016/S1543-1150(03)00010-5
14. Boudreau MD, Beland FA. An evaluation of the biological and toxicological properties of Aloe barbadensis (Miller), Aloe vera. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2006;24(1):103–154. doi:10.1080/10590500600614303
15. Zhang J, Ma S, Wang C, Guo G, Zhou L, Tian X, et al. Screening active constituents against ulcerative colitis by in silico, in vitro and in vivo approaches. Food Funct. 2018;9(10):5124–38. doi:10.1039/C8FO01439F.
16. Lee HJ, Kim GH, Shim JH, Choi DH. Dietary quercetin alleviates DSS-induced colitis in mice by modulating key IBD-related pathways: transcriptome analysis. Bentham Sci. 2020;26:32651963. doi:10.2174/1874078X2021207300019.
17. Li P, Zhang Y, Wang Z, Wang S. Biological activities underlying the therapeutic effects of quercetin on inflammatory bowel disease. Inflammopharmacology. 2022;30(1):23–38. doi:10.1007/s10787-021-00840-x.
18. Ogunwa TH, Rotimi D, Salawu O. Systems pharmacology and docking analysis reveal β-sitosterol interactions with CA-II in inflammatory conditions. J Mol Graph Model. 2021;108:107975. doi:10.1016/j.jmgm.2021.107975.
19. Jiang Y, Yan B, Qin K, Liu X, Duan X, Wang G, et al. Network pharmacology and molecular docking validate quercetin, luteolin, and nobiletin as key anti-UC compounds from Pimpinella candolleana. Front Pharmacol. 2024;15:1328977. doi:10.3389/fphar.2024.1328977.

Ahead of Print Subscription Original Research
Volume 13
01
Received 14/09/2025
Accepted 09/10/2025
Published 17/10/2025
Publication Time 33 Days
224

Login


My IP

PlumX Metrics